Score | |
|---|---|
24h Vol | $23.76 |
Liquidity | $45.8K |
Holders | 3.7K |
Audits | |
Age | 10 months |
FDV | $165.9K |
Market Cap | $158.1K |
About Apex AI (APEX)
Apex AI is an artificial intelligence-driven healthcare startup focused on revolutionizing early detection and predictive diagnostics for gastrointestinal cancers, specifically stomach and colorectal cancer. Apex AI leverages advanced machine learning algorithms and extensive datasets comprising over 1 million endoscopic images to significantly enhance diagnostic accuracy, achieving 95%+ accuracy for stomach cancer and 98%+ for colorectal cancer. The platform provides real-time AI-powered endoscopic analysis, continuous disease monitoring, and precise risk assessment, helping clinicians identify early-stage cancers and precancerous lesions effectively. Apex AI aims to bridge the existing diagnostic gap caused by human error, asymptomatic disease progression, and limited early-stage detection capabilities, ultimately improving patient survival rates and clinical outcomes worldwide.
APEX/SOL Price Stats
The current price of APEX (APEX/SOL) on PumpSwap is $0.0001663, the price is up 0.95% in the last 24 hours. Its 24-hour trading volume is reported to be at $23.76 with a total of 2 transactions. APEX/SOL contract address is 6excFSUG96cteEnTK7vSvXeFGSyZKDzGkis9kwiBVvx7, with a Fully Diluted Valuation (FDV) of $165.94K and a liquidity pool of $45,802.25.
